Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Assets Average (2021 - 2025)

Historic Assets Average for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to $40.0 million.

  • Verrica Pharmaceuticals' Assets Average fell 580.9% to $40.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.0 million, marking a year-over-year decrease of 580.9%. This contributed to the annual value of $67.9 million for FY2024, which is 745.18% up from last year.
  • As of Q3 2025, Verrica Pharmaceuticals' Assets Average stood at $40.0 million, which was down 580.9% from $40.6 million recorded in Q2 2025.
  • Verrica Pharmaceuticals' 5-year Assets Average high stood at $103.6 million for Q2 2021, and its period low was $40.0 million during Q3 2025.
  • Over the past 5 years, Verrica Pharmaceuticals' median Assets Average value was $62.3 million (recorded in 2023), while the average stood at $64.9 million.
  • Its Assets Average has fluctuated over the past 5 years, first skyrocketed by 9042.17% in 2023, then plummeted by 5129.32% in 2024.
  • Quarter analysis of 5 years shows Verrica Pharmaceuticals' Assets Average stood at $84.4 million in 2021, then crashed by 44.42% to $46.9 million in 2022, then skyrocketed by 90.42% to $89.4 million in 2023, then crashed by 51.29% to $43.5 million in 2024, then decreased by 8.11% to $40.0 million in 2025.
  • Its Assets Average stands at $40.0 million for Q3 2025, versus $40.6 million for Q2 2025 and $48.2 million for Q1 2025.